Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted
On Monday, USA Today inadvertently posted a story about the approval of Qsymia, a weight loss drug, several hours before the FDA made an announcement. Today, Amarin, which makes a compound designed to lower triglycerides, put up a site saying that the drug had been approved by the FDA. Trouble was, that decision isn’t expected until July 26. According to Reuters:
Amarin said in a regulatory filing that the information was inadvertently published through a draft website that is under design by third parties on behalf of Amarin.
“The information was outdated and should not be relied upon as accurate,” Amarin said.
“Outdated?” How exactly is information that is not true, but may be true at some future date, “outdated?” Perhaps they meant one day it would be true, a la Mitt Romney’s “retroactively retired” from Bain.